Hiscox Ltd
26 March 2008
HISCOX UK SAYE SHARE OPTION SCHEME
It was noted that the following valid applications to exercise share options
under the Hiscox UK SAYE Share Option Scheme ('UK SAYE Options') had been
received:
Option Holder No. Options Exercise Price
Michael Dobson 7,168 £1.32166
Deborah Reid 1,290 £1.32166
Adele Mary Foster 716 £1.32166
Pascal Paul Christian Lecointe 7,168 £1.32166
Maureen Frances Price 869 £1.5759
Yogan Sabaratnam 3,395 £1.5759
Victoria Armstrong 2,866 £1.32166
Victoria Armstrong 1,740 £1.5759
Victoria Armstrong 225 £2.22
Zoe Bucknell 112 £2.22
David Whitaker 2,866 £1.32166
Suzanne Kemble 7,168 £1.32166
Richard Ian Smellie 1,238 £2.22
Total 36,821
Accordingly IT WAS RESOLVED THAT 36,821 ordinary shares of 5p each be allotted
to the individuals as set out in the table above.
The Secretary would ensure that the necessary forms were filed, would ensure
that the shares were listed and would make the appropriate announcement.
These shares will rank pari passu with the existing ordinary shares of the
company.
SECRETARY
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.